Association of rs2230806 polymorphism with the development of acute cerebrovascular accident in patients with cardiovascular disease
https://doi.org/10.15829/1560-4071-2019-10-29-34
Abstract
Aim. To study the association of single nucleotide polymorphism (SNP) rs2230806 (C>T) with the development of acute cerebrovascular accident (CVA) in East Siberian patients with cardiovascular pathology and risk factors.
Material and methods. The study involved 260 patients with acute CVA (age [57,0; 51,0-62,0]) and 272 patients of control group (age [55,0; 51,0-62,0]). Among patients with acute CVA there were 157 men and 103 women. The control group included 170 men and 102 women. Examination of the experimental group included: acquisition of complaints, anamnesis, clinical examination, computed cerebral tomography, electrocardiography, echocardioscopy, ultrasound duplex scanning of extracranial brachiocephalic arteries, 24-hour monitoring of blood pressure and heart rate, analysis of the blood coagulation system. In patients of the experimental group, the following cardiovascular pathology and risk factors were present: arterial hypertension, paroxysmal supraventricular tachycardia, dyslipidemia, atherosclerosis of the brachiocephalic arteries, hemostatic system disorders. The control group was examined as part of the international HAPIEE project. Molecular genetic studies were performed by real-time PCR.
Results. In all analyzed groups and subgroups of patients, a statistically significant relationship was found between the CC genotype and the C SNP allele rs662799 (A>G) and an increased risk of stroke.
Conclusion. The CC genotype and the C SNP allele rs2230806 (C>T) increases the risk of acute cerebrovascular accident in patients regardless of previous cardiovascular pathology and risk factors, including in patients with arterial hypertension, supraventricular tachyarrhythmias, atherosclerosis of brachiocephalic arteries, and disorders of lipid metabolism and hemostatic system.
Keywords
About the Authors
S. Yu. NikulinaRussian Federation
Competing Interests: not
V. A. Shulman
Russian Federation
Competing Interests: not
A. A. Chernova
Russian Federation
Competing Interests: not
S. V. Prokopenko
Russian Federation
Competing Interests: not
D. A. Nikulin
Russian Federation
Competing Interests: not
I. M. Platunova
Russian Federation
Competing Interests: not
S. S. Tretyakova
Russian Federation
Competing Interests: not
A. A. Semenchukov
Russian Federation
Competing Interests: not
O. V. Marilovtseva
Russian Federation
Competing Interests: not
V. N. Maksimov
Russian Federation
Novosibirsk
Competing Interests: not
A. А. Gurazheva
Russian Federation
Novosibirsk
Competing Interests: not
References
1. Ghaznavi H, Aali E, Soltanpour MS. Association study of the ATP — binding cassette transporter A1 (ABCA1) rs2230806 genetic variation with lipid profile and coronary artery disease risk in an iranian population. Open Access Maced. J. Med. Sci. 2018;6(2):274-79. doi:10.3889/oamjms.2018.063.
2. Ma XY, Liu JP, Song ZY. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Atherosclerosis. 2011 ;215(2):428-34. doi:10.1016/j.atherosclerosis.2011.01.008.
3. Pasdar A, Yadegarfar G, Cumming A, et al. The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. BMC Med. Genet. 2007;8:30. doi:10.1186/1471-2350-8-30.
4. Akao H, Polisecki E, Schaefer EJ, et al. ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis. 2014;235(1):176-81. doi:10.1016/j.atherosclerosis.2014.04.030.
5. Berard AM, Bedel A, Le Trequesser R, et al. Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study. PLoS One. 2013;8(3):e37882. doi:10.1371/journal.pone.0037882.
6. Haghvirdizadeh P, Ramachandran V, Etemad A, et al. Association of ATP-binding cassette transporter A1 gene polymorphisms in type 2 diabetes mellitus among Malaysians. J. Diabetes Res. 2015;2015:289846. doi:10.1155/2015/289846.
7. Wollmer MA, Streffer JR, Lutjohann D, et al. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging. 2003;24(3):421-6.
8. Sundar PD, Feingold E, Minster RL, et al. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging. 2007;28(6):856-62. doi:10.1016/j.neurobiolaging.2006.04.005.
9. Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255. doi:10.1186/1471-2458-6-255
10. Borovikov VP. STATISTICA: the art of data analysis on a computer. SPb.: Peter, 2001. p. 656. (In Russ.) ISBN 5-272-00078-1.
11. Petri A, Sabin K. Visual Medical Statistics: study guide: trans. from English; by ed. VP Leonov; 3rd ed., Pererab. and add. M.: GEOTAR-Media 2015. p. 216. (In Russ.) ISBN: 978-5-9704-1676-1.
Review
For citations:
Nikulina S.Yu., Shulman V.A., Chernova A.A., Prokopenko S.V., Nikulin D.A., Platunova I.M., Tretyakova S.S., Semenchukov A.A., Marilovtseva O.V., Maksimov V.N., Gurazheva A.А. Association of rs2230806 polymorphism with the development of acute cerebrovascular accident in patients with cardiovascular disease. Russian Journal of Cardiology. 2019;(10):29-34. (In Russ.) https://doi.org/10.15829/1560-4071-2019-10-29-34